ALCAINE

This brand name is authorized in United States. It is also authorized in Canada, Cyprus, Ecuador, Estonia, Hong Kong SAR China, Lithuania, New Zealand, Poland, Singapore, Turkey.

Active ingredients

The drug ALCAINE contains one active pharmaceutical ingredient (API):

1	Proparacaine UNII U96OL57GOY - PROPARACAINE HYDROCHLORIDE
	Proxymetacaine is a potent topical anaesthetic of the ester type. The main site of anaesthetic action is the nerve cell membrane where proxymetacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarisation of the membrane.
	Read more about Proparacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALCAINE Eye drops, solution	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01HA04	Proxymetacaine	S Sensory organs → S01 Ophthalmologicals → S01H Local anesthetics → S01HA Local anesthetics
Discover more medicines within S01HA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00035076
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.838-08-04
EE	Ravimiamet	1123849
HK	Department of Health Drug Office	21472
LT	Valstybinė vaistų kontrolės tarnyba	1010023
NZ	Medicines and Medical Devices Safety Authority	14831
PL	Rejestru Produktów Leczniczych	100003640
SG	Health Sciences Authority	04718P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699760611360
US	FDA, National Drug Code	0998-0016